Renhe Capital logo

Renhe Capital

Asia, Guangdong, China, Shenzhen

Description

Renhe Capital is a asset management company.

Investor Profile

Renhe Capital has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 8 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series D rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Health Care, Medical, Sensor.

Stage Focus

  • Series B (67%)
  • Series D (33%)

Country Focus

  • China (100%)

Industry Focus

  • Health Care
  • Medical
  • Sensor
  • Wearables
  • Biotechnology
  • Genetics
  • Life Science
  • Artificial Intelligence (Ai)
  • Information Technology
  • Robotics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Renhe Capital frequently co-invest with?

TSVC
North America, California, United States, Los Altos
Co-Investments: 1
JB Capital
North America, Washington, United States, Bellevue
Co-Investments: 1
Fosun RZ Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Hongtai Capital Holdings
Asia, Beijing, China, Beijing
Co-Investments: 1
THG Ventures
Asia, Beijing, China, Beijing
Co-Investments: 1
Ant Group
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Co-Investments: 1
Green Pine Capital Partners
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Renzhi Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Haitong Capital
Europe, Lisboa, Portugal, Lisbon
Co-Investments: 1

What are some of recent deals done by Renhe Capital?

Thoth Medical

Suzhou, Jiangsu, China

Thoth Medical develops medical wearables integrating biomedical sensor technology.

Health CareMedicalSensorWearables
Series BJan 1, 2020
Orbbec

Shenzhen, Guangdong, China

The Orbbec mission is to create intelligent technologies for every human, everywhere through 3D image sensors and smart cameras.

Artificial Intelligence (AI)Information TechnologyRobotics
Series DMay 21, 2018
Amount Raised: $200,000,000
ACCB Biotech

Beijing, Beijing, China

Beijing ACCB Biotech is focused on the R&D of cancer detection methods through the application of molecular biology technologies.

BiotechnologyGeneticsHealth CareLife Science
Series BOct 1, 2016